<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36317108</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-5476</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Clinical medicine insights. Case reports</Title><ISOAbbreviation>Clin Med Insights Case Rep</ISOAbbreviation></Journal><ArticleTitle>Kratom-Associated Mixed Cholestatic-Hepatocellular Liver Injury in a Patient With Long COVID: A case Report.</ArticleTitle><Pagination><StartPage>11795476221132824</StartPage><MedlinePgn>11795476221132824</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11795476221132824</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/11795476221132824</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED"><i>Mitragyna speciosa</i> (commonly known as kratom) has both opioid and stimulant-like effects. Recently, Thailand decriminalized the possession and sale of kratom which led people in many areas to seek income from the sale of kratom at a time of widespread unemployment due to COVID-19. Here, we report a patient with post-COVID syndrome who developed a mixed cholestatic-hepatocellular liver injury secondary to kratom.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="UNASSIGNED">A 23-year-old Thai man was seen for an evaluation of fatigue and nausea which was soon followed by pruritus, dark urine and jaundice. The patient had no known underlying disease but had been treated with mild COVID-19 pneumonia in the past 2&#x2009;months. He reported taking kratom recreationally for 2&#x2009;weeks as a treatment for his post-COVID insomnia. Kratom was purchased from a friend and used in a homemade iced cocktail called "4&#x2009;&#xd7;&#x2009;100" consisting of Coca-Cola, tea made from boiled kratom leaves, and diphenhydramine-containing cough syrup which has been popular in Southernmost provinces of Thailand. His lab workup showed his total bilirubin to be 10.6&#x2009;mg/dL, aspartate aminotransferase was 642&#x2009;U/L, and alanine aminotransferase was 1635&#x2009;U/L. Extensive workups including viral etiologies was negative. Abdominal ultrasound revealed normal liver and no cirrhosis. The case was managed conservatively for 5&#x2009;days in the hospital by giving intravenous fluid and stopping all medications. Urine toxicology screening confirmed the presence of mitragynine and diphenhydramine. He was in a stable condition with normalized liver function tests at 3&#x2009;months after discharge.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The COVID-19 pandemic has posed unprecedented challenges to health consequences and this case highlights the importance of kratom as potential cause of acute liver injury. Future studies should accumulate further case series and identify kratom-user subgroups or the polydrug patterns of kratom use that are at heightened risk of severe liver injury.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thewjitcharoen</LastName><ForeName>Yotsapon</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2317-4041</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Theptarin Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krittiyawong</LastName><ForeName>Sirinate</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Theptarin Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakasatien</LastName><ForeName>Soontaree</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Theptarin Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Himathongkam</LastName><ForeName>Thep</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Theptarin Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Med Insights Case Rep</MedlineTA><NlmUniqueID>101531893</NlmUniqueID><ISSNLinking>1179-5476</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Kratom</Keyword><Keyword MajorTopicYN="N">Mitragyna speciosa</Keyword><Keyword MajorTopicYN="N">case report</Keyword><Keyword MajorTopicYN="N">cholestatic liver injury</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>1</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36317108</ArticleId><ArticleId IdType="pmc">PMC9614595</ArticleId><ArticleId IdType="doi">10.1177/11795476221132824</ArticleId><ArticleId IdType="pii">10.1177_11795476221132824</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Suwanlert S. A study of kratom eaters in Thailand. Bull Narc. 1975;27:21-27.</Citation><ArticleIdList><ArticleId IdType="pubmed">1041694</ArticleId></ArticleIdList></Reference><Reference><Citation>Adkins JE, Boyer EW, McCurdy CR. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Curr Top Med Chem. 2011;11:1165-1175.</Citation><ArticleIdList><ArticleId IdType="pubmed">21050173</ArticleId></ArticleIdList></Reference><Reference><Citation>Trakulsrichai S, Tongpo A, Sriapha C, et al.. Kratom abuse in ramathibodi Poison Center, Thailand: a five-year experience. J Psychoactive Drugs. 2013;45:404-408.</Citation><ArticleIdList><ArticleId IdType="pubmed">24592666</ArticleId></ArticleIdList></Reference><Reference><Citation>
The curse and cure of kratom
2015, Bangkok Post. Accessed 5 January 2022. https://www.bangkokpost.com/thailand/special-reports/681964/the-curse-and-cure-of-kratom.</Citation></Reference><Reference><Citation>Singh D, Narayanan S, Vicknasingam B, Corazza O, Santacroce R, Roman-Urrestarazu A. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia. Hum Psychopharmacol Clin Exp. 2017;32:e2582.</Citation><ArticleIdList><ArticleId IdType="pubmed">28544011</ArticleId></ArticleIdList></Reference><Reference><Citation>Tungtananuwat W, Lawanprasert S. Fatal 4x100; home-made Kratom Juice Cocktail. J Health Res. 2018;24:43-47.</Citation></Reference><Reference><Citation>Chodchoy P, Sinchai T. The relationship between mitragynine blood concentrat:ions and death in Thailand. Interdiscip Res Rev. 2020;15:18-21.</Citation></Reference><Reference><Citation>Bluhm R, Zsigmond EK, Winnie AP. Potentiation of opioid analgesia by H1 and H2 antagonists. Life Sci. 1982;31:1229-1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">6128651</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and kratom. Clin Toxicol. 2008;46:146-152.</Citation><ArticleIdList><ArticleId IdType="pubmed">18259963</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre IM, Trochta A, Stolberg S, Campman SC. Mitragynine &#x2018;Kratom&#x2019; related fatality: a case report with postmortem concentrations. J Anal Toxicol. 2015;39:152-155.</Citation><ArticleIdList><ArticleId IdType="pubmed">25516573</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kratom death adverse event reports &#x2013; USFDA Adverse Event Reporting System (FAERS). Accessed 21 June 2022. https://www.fda.gov/files/drugs/published/Adverse-event-reports-for-Kratom-involoving-death.pdf.</Citation></Reference><Reference><Citation>Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;173:61-62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138334</ArticleId><ArticleId IdType="pubmed">32240293</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor S, Paluszek MM, Rachor GS, McKay D, Asmundson GJG. Substance use and abuse, COVID-19-related distress, and disregard for social distancing: A network analysis. Addict Behav. 2021;114:106754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164919</ArticleId><ArticleId IdType="pubmed">33310690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al.. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601-615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmel J, Dart RC. Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review. Drugs. 2020;80:263-283.</Citation><ArticleIdList><ArticleId IdType="pubmed">31919755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad J, Odin JA, Hayashi PH, et al.. Liver injury associated with kratom, a popular opioid-like product: experience from the U.S. Drug induced liver injury network and a review of the literature. Drug Alcohol Depend. 2021;218:108426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113016</ArticleId><ArticleId IdType="pubmed">33257199</ArticleId></ArticleIdList></Reference><Reference><Citation>Corkery JM, Streete P, Claridge H, et al.. Characteristics of deaths associated with kratom use. J Psychopharmacol. 2019;33:1102-1123.</Citation><ArticleIdList><ArticleId IdType="pubmed">31429622</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke DJ, Mahonski SG, Van Cott AC. Breakthrough seizure associated with kratom use in patients with epilepsy. Neurol Clin Pract. 2021;11:78-84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8101317</ArticleId><ArticleId IdType="pubmed">33968476</ArticleId></ArticleIdList></Reference><Reference><Citation>Danan G, Benichou C. Causality assessment of adverse reactions to drugs&#x2013;I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46:1323-1330.</Citation><ArticleIdList><ArticleId IdType="pubmed">8229110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail S, Haron M. Effects of mitragynine and 7-hydroxymitragynine (the alkaloids of Mitragyna speciosa Korth) on 4-methylumbelliferone glucuronidation in rat and human liver microsomes and recombinant human uridine 5&#x2032;-diphospho-glucuronosyltransferase isoforms. Pharmacogn Res. 2015;7:341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4660513</ArticleId><ArticleId IdType="pubmed">26692748</ArticleId></ArticleIdList></Reference><Reference><Citation>European Association for the Study of the Liver. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019;70:1222-1261.</Citation><ArticleIdList><ArticleId IdType="pubmed">30926241</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021;116:878-898.</Citation><ArticleIdList><ArticleId IdType="pubmed">33929376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie C, Thompson M. Salmonella contaminated kratom ingestion associated with fulminant hepatic failure requiring liver transplantation. Clin Toxicol. 2018;56:947.</Citation></Reference><Reference><Citation>Khan MZ, Saleh MA, Alkhayyat M, Roberts DE, Lindenmeyer CC. Multiorgan dysfunction related to kratom ingestion. ACG Case Rep J. 2021;8:e00647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389947</ArticleId><ArticleId IdType="pubmed">34476274</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman AI, McLeod HM, Ventresca EC, et al.. Medical Cannabis State and federal regulations: Implications for United States Health Care Entities. Mayo Clin Proc. 2021;96:2671-2681.</Citation><ArticleIdList><ArticleId IdType="pubmed">34607636</ArticleId></ArticleIdList></Reference><Reference><Citation>Post S, Spiller HA, Chounthirath T, Smith GA. Kratom exposures reported to United States poison control centers: 2011-2017. Clin Toxicol. 2019;57:847-854.</Citation><ArticleIdList><ArticleId IdType="pubmed">30786220</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Romeu A, Cox DJ, Smith KE, Dunn KE, Griffiths RR. Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic. Drug Alcohol Depend. 2020;208:107849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7423016</ArticleId><ArticleId IdType="pubmed">32029298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang QQ, Kaelber DC, Xu R, Volkow ND. Correction: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26:40-49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7526074</ArticleId><ArticleId IdType="pubmed">32999436</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>